You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanocortin-4 Receptor Gene

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bardet-Biedl Syndrome, POMC Deficiency Trial in Marshfield (Setmelanotide 20mg weekly, Placebo daily, Setmelanotide 30mg weekly)

Enrolling by invitation
  • Bardet-Biedl Syndrome
  • POMC Deficiency
  • Setmelanotide 20mg weekly
  • +5 more
  • Marshfield, Wisconsin
    Marshfield Clinic Research Institute
Jan 25, 2022

Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway Trial (Setmelanotide, Placebo)

Not yet recruiting
  • Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway
  • (no location specified)
Oct 13, 2021

Genetic Obesity Trial in Spain, United Kingdom, United States (Setmelanotide, Placebo)

Recruiting
  • Genetic Obesity
  • Dearborn, Michigan
  • +13 more
Jun 14, 2022

Hypoactive Sexual Desire Disorder Trial in London (Bremelanotide, Placebo)

Recruiting
  • Hypoactive Sexual Desire Disorder
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Mar 9, 2022

Overweight Trial in United States (RM-493, Placebo)

Completed
  • Overweight
  • Miami, Florida
  • +5 more
Nov 14, 2022

Obesity Associated With Defects in Leptin-melanocortin Pathway Trial in Worldwide (Setmelanotide)

Enrolling by invitation
  • Obesity Associated With Defects in Leptin-melanocortin Pathway
  • Chandler, Arizona
  • +31 more
Dec 6, 2022

T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

Recruiting
  • T-cell Lymphoma
  • T-cell Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Dec 16, 2022

Lymphocytes of Polymyalgia Patients

Completed
  • Polymyalgia Rheumatica
  • Blood samples before and after standard of care of polymyalgia rheumatica
  • (no location specified)
Jan 11, 2023

Bardet Biedl Syndrome (BBS), Alström Syndrome (AS) Trial in Worldwide (Setmelanotide, Placebos)

Completed
  • Bardet Biedl Syndrome (BBS)
  • Alström Syndrome (AS)
  • San Diego, California
  • +11 more
Jul 19, 2021

Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood

Completed
Has Results
  • Cervical Cancer
  • +4 more
  • Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Genetic Forms of Extreme Obesity Trial in Columbus, Edmonton

Completed
  • Genetic Forms of Extreme Obesity
    • Columbus, Ohio
    • +1 more
    Apr 30, 2021

    Gene Recurrence Score on Chemotherapy Prescribing in ER

    Active, not recruiting
    • Breast Cancer
      • Letterkenny, Co. Donegal, Ireland
      • +9 more
      Jan 14, 2022

      Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

      Terminated
      Has Results
      • Acute Myeloid Leukemia
      • +4 more
      • Aldesleukin
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 15, 2021

      Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

      Active, not recruiting
      • Anatomic Stage 0 Breast Cancer AJCC v8
      • +21 more
      • Ipilimumab
      • +2 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Sep 22, 2022

      Leptin Receptor Deficiency Obesity Trial in Worldwide (setmelanotide, Placebo)

      Completed
      • Leptin Receptor Deficiency Obesity
      • New York, New York
      • +6 more
      Jan 26, 2021

      Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

      Not yet recruiting
      • Melanoma (Skin)
      • +5 more
      • Iowa City, Iowa
      • +2 more
      Dec 8, 2022

      Fat Metabolism and Melanocortin 3 Receptors in African Americans

      Terminated
      • Obesity
      • Healthy Volunteers
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jun 29, 2021

        Cholangiocarcinoma Trial in China, Japan (E7090)

        Active, not recruiting
        • Cholangiocarcinoma
        • Bengbu, Anhui, China
        • +55 more
        Jan 24, 2023

        Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)

        Not yet recruiting
        • Obesity, Child
        • sequencing of a panel of 14 genes in leptin melanocortin pathway
        • (no location specified)
        Jul 3, 2023

        A Model for Genetic Susceptibility: Melanoma

        Active, not recruiting
        • Melanoma
        • Skin Cancer
        • Questionnaire
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Jan 13, 2022

        Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

        Recruiting
        • Kidney Disease
        • Chula Vista, California
        • +5 more
        Jan 23, 2023

        Vit D Receptor Gene Polymorphism

        Completed
        • Vitamin D Status
        • questionnaire
        • Mangaluru, Karnataka, India
          AB shetty Institute of dental sciences
        Jul 1, 2023

        Obesity, Adolescent Trial in Holbæk, Copenhagen (TCOC treatment, Semaglutide 3 mg)

        Recruiting
        • Obesity, Adolescent
        • TCOC treatment
        • Semaglutide 3 mg
        • Holbæk, Region Zeeland, Denmark
        • +1 more
        Oct 18, 2022

        atoGepant In reaAl Life iN iTaly

        Not yet recruiting
        • Migraine, Prophylaxis
        • (no location specified)
        Nov 13, 2023